Svoboda | Graniru | BBC Russia | Golosameriki | Facebook

Access Statistics for Anirban Basu

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Comparing 2SLS vs 2SRI for Binary Outcomes and Binary Exposures 0 0 0 46 0 0 0 80
Do For-Profit Hospitals Cream-Skim Patients? Evidence from Inpatient Psychiatric Care in California 0 9 10 10 1 6 11 11
Dynamic Efficiency and Pricing of Innovations with Insurance: The Case for Gene Therapies 4 4 4 4 7 10 10 10
Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care 0 0 2 47 0 0 3 174
Estimating Lifetime or Episode-of-illness Costs 1 1 2 108 1 1 4 283
Estimating Person-Centered Treatment (PeT) Effects Using Instrumental Variables 0 0 0 52 0 0 0 153
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 1 39 0 0 1 182
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 18 0 0 0 97
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 0 290 0 0 2 871
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 1 44 0 0 2 157
Hidden Figures: Uncovering Quantities Behind Zeros with Econometrics 0 0 15 15 0 0 19 19
Impact of Rural and Urban Hospital Closures on Inpatient Mortality 0 2 2 85 1 5 12 149
Political Polarization, Anticipated Health Insurance Uptake and Individual Mandate: A view from the Washington State 0 0 0 16 0 0 0 37
Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting 0 1 2 62 0 2 5 92
Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion 0 0 0 50 0 0 1 34
Service-level Selection: Strategic Risk Selection in Medicare Advantage in Response to Risk Adjustment 0 0 0 7 0 0 0 49
The Impact of Comparative Effectiveness Research on Health and Health Care Spending 0 0 0 57 0 0 0 228
The New Prescription Drug Paradox: Pipeline Pressure and Rising Prices 0 0 0 73 1 1 8 100
The Roles of Cognitive and Non-Cognitive Skills in Moderating the Effects of Mixed-Ability Schools on Long-Term Health 0 0 0 42 0 0 1 100
The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures 0 0 0 42 1 1 1 158
Understanding Algorithmic Discrimination in Health Economics Through the Lens of Measurement Errors 0 0 0 21 0 1 3 49
Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures 0 0 0 53 0 1 1 216
Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients 0 0 0 481 0 0 2 1,335
Use of propensity scores in non-linear response models: The case for health care expenditures 0 0 0 146 0 0 7 514
Welfare Implications of Learning Through Solicitation versus Diversification in Health Care 0 0 0 36 0 0 0 55
Total Working Papers 5 17 39 1,844 12 28 93 5,153


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
CAN WE MAKE SMART CHOICES BETWEEN OLS AND CONTAMINATED IV METHODS? 0 0 0 3 1 1 1 24
Comparing alternative models: log vs Cox proportional hazard? 0 0 0 146 1 1 1 567
Does Competition under Medicare Prospective Payment Selectively Reduce Expenditures on High-Cost Patients? 0 0 0 0 0 0 0 313
ESTIMATING PERSON‐CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS 0 0 0 6 0 1 1 39
Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care 0 0 0 29 0 0 2 241
Erratum: Estimating lifetime or episode‐of‐illness costs under censoring 0 0 0 15 0 0 0 46
Estimating lifetime or episode‐of‐illness costs under censoring 0 0 1 20 1 1 2 78
Extended generalized linear models: Simultaneous estimation of flexible link and variance functions 0 1 2 144 1 2 6 416
Generalized modeling approaches to risk adjustment of skewed outcomes data 0 1 3 142 0 1 7 356
HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH 0 0 0 2 0 0 0 24
HIGHLIGHTING DIFFERENCES BETWEEN CONDITIONAL AND UNCONDITIONAL QUANTILE REGRESSION APPROACHES THROUGH AN APPLICATION TO ASSESS MEDICATION ADHERENCE 0 1 3 102 0 2 10 282
Implications of spillover effects within the family for medical cost-effectiveness analysis 0 0 0 72 0 2 5 184
Measuring the Value of Pharmaceuticals in the US Health System 0 0 0 5 0 0 0 14
Person-centered treatment (PeT) effects: Individualized treatment effects using instrumental variables 0 0 3 37 0 5 10 141
Personalized Medicine in the Context of Comparative Effectiveness Research 0 0 0 13 0 0 1 101
Private Manufacturers’ Thresholds to Invest in Comparative Effectiveness Trials 0 0 0 5 0 0 0 47
RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION” 0 0 0 1 0 0 0 17
Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity 0 0 0 52 0 0 1 217
The impact of comparative effectiveness research on health and health care spending 0 0 1 35 0 0 2 273
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling 0 3 3 917 2 10 17 2,682
Welfare implications of learning through solicitation versus diversification in health care 0 0 0 2 0 0 0 34
Total Journal Articles 0 6 16 1,748 6 26 66 6,096


Software Item File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
IVCHECK: Stata module to choose between OLS and contaminated IV 0 0 0 24 0 2 6 221
Total Software Items 0 0 0 24 0 2 6 221


Statistics updated 2024-07-03